Neuland Laboratories - Quaterly Results

The sales for the September 2024 quarter moved down to Rs. 3108.44 millions as compared to Rs. 4177.49 millions during the year-ago period.A big decline of -64.12% was reported for the quarter ended September 2024 to Rs. 319.59  millions from Rs. 890.65 millions of corresponding previous quarter.A decline of 656.75 millions was observed in the OP in the quarter ended September 2024 from 1403.46 millions on QoQ basis.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202409	202309	% Var	202409	202309	% Var	202403	202303	% Var
Sales	3108.44	4177.49	-25.59	7504.46	7807.43	-3.88	15585.80	11911.98	30.84
Other Income	43.32	30.48	42.13	91.39	50.87	79.65	125.44	97.48	28.68
PBIDT	656.75	1403.46	-53.20	1943.08	2396.50	-18.92	4744.65	2810.56	68.82
Interest	10.63	44.33	-76.02	37.34	66.47	-43.82	139.97	130.67	7.12
PBDT	646.12	1359.13	-52.46	2112.00	2330.03	-9.36	4604.68	2679.89	71.82
Depreciation	160.73	145.08	10.79	323.52	280.94	15.16	596.99	527.76	13.12
PBT	485.39	1214.05	-60.02	1788.48	2049.09	-12.72	4007.69	2152.13	86.22
TAX	165.80	323.40	-48.73	485.50	536.20	-9.46	1011.73	520.94	94.21
Deferred Tax	43.68	9.03	383.72	57.57	12.36	365.78	15.87	17.04	-6.87
PAT	319.59	890.65	-64.12	1302.98	1512.89	-13.87	2995.96	1631.19	83.67
Equity	129.01	129.01	0.00	129.01	129.01	0.00	129.01	129.01	0.00
PBIDTM(%)	21.13	33.60	-37.11	25.89	30.70	-15.65	30.44	23.59	29.02